Early Tumor Shrinkage With Cabozantinib Improves Survival in Renal Cell Carcinoma

New analysis shows that early tumor shrinkage with cabozantinib is associated with longer survival compared with everolimus.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2SSRLcK